Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Good clinical practices in phase I studies.

H Decousus1, B Perpoint, P Mismetti

  • 1Service de Médecine Interne et de Thérapeutique, Hôpital de Bellevue, Saint-Etienne, France.

Fundamental & Clinical Pharmacology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Translation into French and republication of: "Management of cancer-associated thromboembolism in vulnerable population"].

La Revue de medecine interne·2024
Same author

[Translation into French and republication of: "Anticoagulant treatment of cancer-associated thromboembolism"].

La Revue de medecine interne·2024
Same author

[Care pathway for patients with cancer-associated thrombosis: proposals for multidisciplinary clinical practice, under the aegis of INNOVTE (Investigation Network On Venous ThromboEmbolism) network].

La Revue de medecine interne·2024
Same author

Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database.

BMC cancer·2023
Same author

Prevention of venous thromboembolic events in patients with lower leg immobilization after trauma: Systematic review and network meta-analysis with meta-epsidemiological approach.

PLoS medicine·2022
Same author

[Treatment of cancer associated thrombosis. 2019 update of the French guidelines].

Revue des maladies respiratoires·2021

France has established comprehensive legal guidelines for good clinical practices in phase I clinical trials. These regulations ensure subject safety through strict protocols for recruitment, investigator competence, facility standards, and quality control.

Area of Science:

  • Clinical Research
  • Regulatory Affairs
  • Pharmacology

Background:

  • Official guidelines for good clinical practices (GCP) in clinical trials were first issued in France in 1987.
  • A pivotal law in December 1988 established requirements for conducting experiments on healthy subjects.
  • Further guidelines are being developed for facilities conducting experiments on healthy subjects and patients when not for direct health benefit.

Purpose of the Study:

  • To outline the current legal framework defining good clinical practices for Phase I studies in France.
  • To highlight key regulatory components essential for the ethical and safe conduct of early-phase clinical trials.

Main Methods:

  • Review of French legal instructions and official guidelines pertaining to clinical trial conduct.

Related Experiment Videos

  • Analysis of regulatory requirements for Phase I studies, focusing on subject protection and data integrity.

    • Main Results:

    • Recent legal instructions precisely define good clinical practices for Phase I studies.
    • Key areas emphasized include subject recruitment/selection, investigator qualifications, safety facilities, and quality control.

    Conclusions:

    • France has implemented a robust legal structure for good clinical practices in Phase I clinical trials.
    • Adherence to these regulations is crucial for ensuring subject safety and the reliability of trial data.